疫苗前沿 | 突破mRNA应用的局限，这一技术能带来新一代疗法吗？

疫苗前沿 | 突破mRNA应用的局限，这一技术能带来新一代疗法吗？重生之制造帝国,广东好心情食品集团有限公司,芜湖市安全教育平台, 作者：预防界. 参考资料： [1] ATP Announces $40 Million in Series A Funding for srRNA Therapeutics Trailblazer Replicate Bioscience. Retrieved September 8, 2021, from https://w

作者：预防界.

参考资料：

[1] ATP Announces $40 Million in Series A Funding for srRNA Therapeutics Trailblazer Replicate Bioscience. Retrieved September 8, 2021, from https://www.prnewswire.com/news-releases/atp-announces-40-million-in-series-a-funding-for-srrna-therapeutics-trailblazer-replicate-bioscience-301370789.html

[2] Spurred on by Moderna and Pfizer's success, a Belgian biotech has big ambitions for its self-amplifying RNA vaccine play. Retrieved September 8, 2021, from https://endpts.com/spurred-on-by-moderna-and-pfizers-success-a-belgian-biotech-has-big-ambitions-for-its-self-amplifying-rna-vaccine-play/

[3] Bloom et al., (2020). Self-amplifying RNA vaccines for infectious diseases. Gene Therapy, https://doi.org/10.1038/s41434-020-00204-y

注：本文旨在介绍医药健康研究进展，不是治疗方案推荐。如需获得治疗方案指导，请前往正规医院就诊。

来源：药明康德

本文转载自其他网站，不代表健康界观点和立场。如有内容和图片的著作权异议，请及时联系我们（邮箱：guikequan@hmkx.cn）

淄博市商务局,今日财运在哪个方向,今年退市的股票, http://www.xinzhiliao.com/zx/jinji/37810.html